Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating ...

Johnson & Johnson, while primarily known as America's leading healthcare company, now employs nearly 7,000 digital specialists and data scientists.

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...

Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”), a clinical-stage biopharmaceutical company pioneering the discovery and development of peptide-based therapeutics, today announced that ...